These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24622039)

  • 1. Early changes in serum visfatin after abdominal surgery: a new pro-inflammatory marker in diagnosis?
    Teplan V; Senolt L; Hulejova H; Teplan V; Stollova M; Gurlich R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):489-96. PubMed ID: 24622039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamics of serum visfatin level after abdominal surgery: a new proinflammatory marker in the early diagnosis?].
    Teplan V; Šenolt L; Hulejová H; Teplan V; Štollová M; Gürlich R
    Cas Lek Cesk; 2013; 152(5):226-32. PubMed ID: 24131460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
    J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance.
    Hetta HF; Ez-Eldeen ME; Mohamed GA; Gaber MA; ElBadre HM; Ahmed EA; Abdellatief RB; Abd-ElBaky RM; Elkady A; Nafee AM; Zahran AM; Ahmad M
    Egypt J Immunol; 2018 Jun; 25(2):141-151. PubMed ID: 30600957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
    Oki K; Yamane K; Kamei N; Nojima H; Kohno N
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
    Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
    Chang YC; Chang TJ; Lee WJ; Chuang LM
    Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between visfatin and serum concentrations of C-reactive protein, interleukin 6 in patients with metabolic syndrome.
    Hosseinzadeh-Attar MJ; Golpaie A; Foroughi M; Hosseinpanah F; Zahediasl S; Azizi F
    J Endocrinol Invest; 2016 Aug; 39(8):917-22. PubMed ID: 27023106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body fat distribution has no effect on serum visfatin levels in healthy female subjects.
    Ersoy C; Sadikoglu G; Orhan H; Guclu M; Sarandol E; Akgun MD; Ozcakir A; Imamoglu S
    Cytokine; 2010 Mar; 49(3):275-8. PubMed ID: 20045351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
    Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
    Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
    Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
    Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines.
    Terra X; Auguet T; Quesada I; Aguilar C; Luna AM; Hernández M; Sabench F; Porras JA; Martínez S; Lucas A; Pellitero S; Llutart J; del Castillo D; Richart C
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):691-8. PubMed ID: 22182404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of portal and systemic blood cytokines after colectomy in patients with carcinoma or Crohn's disease.
    Riché F; Dosquet C; Panis Y; Valleur P; Laisné MJ; Briard C; Wautier JL
    J Am Coll Surg; 1995 Jun; 180(6):718-24. PubMed ID: 7773486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.
    Moschen AR; Molnar C; Wolf AM; Weiss H; Graziadei I; Kaser S; Ebenbichler CF; Stadlmann S; Moser PL; Tilg H
    J Hepatol; 2009 Oct; 51(4):765-77. PubMed ID: 19664840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
    Malavazos AE; Ermetici F; Cereda E; Coman C; Locati M; Morricone L; Corsi MM; Ambrosi B
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):523-30. PubMed ID: 18083357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose.
    de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O
    Nutrition; 2013; 29(11-12):1300-3. PubMed ID: 19131213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
    Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
    Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
    Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
    Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visfatin levels in female, morbid, nondiabetic obese patients after biliopancreatic diversion surgery.
    de Luis DA; Izaola O; Conde R; Primo D; Sagrado MG; Aller R
    Surg Obes Relat Dis; 2011; 7(2):195-8. PubMed ID: 21036106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.